Unknown PHASE3 INTERVENTIONAL 2-arm NCT03521986

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Postoperative Pain and Quality of Life for Patients Undergoing Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS：A Randomized Controlled Trial

Sponsor: Lei Jiang

Conditions Mediastinal Neoplasms Thoracic Neoplasm Thoracic Surgery

Interventions Intercostal uniportal VATS Subxiphoid uniportal VATS

Updated 9 times since 2018 Last updated: May 10, 2022 Started: Apr 4, 2018 Primary completion: Oct 30, 2023 Completion: Oct 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Mediastinal Neoplasms and Thoracic Neoplasm, this trial is ongoing. The trial is conducted by Lei Jiang and has accumulated 9 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting PHASE3
Apr 2021 — Jun 2022 [monthly]

Recruiting PHASE3

▶ Show 4 earlier versions

Jan 2021 — Apr 2021 [monthly]

Recruiting PHASE3
Apr 2020 — Jan 2021 [monthly]

Recruiting PHASE3
Oct 2019 — Apr 2020 [monthly]

Recruiting PHASE3
Jun 2018 — Oct 2019 [monthly]

Recruiting PHASE3

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lei Jiang

Data source: Shanghai Pulmonary Hospital, Shanghai, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China